메뉴 건너뛰기




Volumn 31, Issue 4, 2000, Pages 840-845

Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma

(81)  Pererrone, Francesco a,aa   Daniele, Bruno a   Battista Gaeta, Giovanni k   Pignata, Sandro a   Gallo, Ciro z,aa   Izzo, Francesco a   Cuomo, Oreste b   Capuano, Gaetano c   Ruggiero, Giuseppe d   Mazzanti, Roberto e   Farinati, Fabio f   Elba, Silvana g   Cremona, Francesco a   Parisi, Valerio a   Fiore, Francesco a   Vallone, Paolo a   Di Palma, Massimo b   Manno, Emilio b   Militerno, Giuseppe b   Budillon, Gabriele c   more..

i SUN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; TAMOXIFEN;

EID: 0034107047     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/he.2000.5628     Document Type: Article
Times cited : (508)

References (18)
  • 4
    • 0031782818 scopus 로고    scopus 로고
    • A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
    • The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. HEPATOLOGY 1998;28:751-755.
    • (1998) Hepatology , vol.28 , pp. 751-755
  • 5
    • 0032482661 scopus 로고    scopus 로고
    • Tamoxifen in the treatment of hepatocellular carcinoma: A randomised controlled trial
    • CLIP Group (Cancer of the Liver Italian Program). Tamoxifen in the treatment of hepatocellular carcinoma: a randomised controlled trial. Lancet 1998;352:17-20.
    • (1998) Lancet , vol.352 , pp. 17-20
  • 6
    • 33845382806 scopus 로고
    • Non parametric estimation from incomplete observation
    • Kaplan EL, Meier E Non parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-481.
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, E.2
  • 7
    • 0013886333 scopus 로고
    • Evaluation of survival data and two new rank order statistics arising in its consideration
    • Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
    • (1966) Cancer Chemother Rep , vol.50 , pp. 163-170
    • Mantel, N.1
  • 8
    • 0000336139 scopus 로고
    • Regression models and life tables
    • Cox DR. Regression models and life tables. J R Stat Soc Series B 1972;34:187-220.
    • (1972) J R Stat Soc Series B , vol.34 , pp. 187-220
    • Cox, D.R.1
  • 9
    • 0011678771 scopus 로고    scopus 로고
    • Akaike's criteria
    • Armitage P, Colton T, eds. Chichester: Wiley
    • Stone M: Akaike's criteria. In: Armitage P, Colton T, eds. Encyclopedia of Biostatistics. Chichester: Wiley, 1998;123-124.
    • (1998) Encyclopedia of Biostatistics , pp. 123-124
    • Stone, M.1
  • 10
    • 0025286476 scopus 로고
    • Measures of explained variation for survival data
    • Korn EL, Simon R. Measures of explained variation for survival data. Stat Med 1990;9:487-503.
    • (1990) Stat Med , vol.9 , pp. 487-503
    • Korn, E.L.1    Simon, R.2
  • 11
    • 0033066135 scopus 로고    scopus 로고
    • A new prognostic classification for predicting survival in patients with hepatocellular carcinoma
    • Chevret S, Trinchet JC, Mathieu D, Rached AA, Beaugrand M, Chastang C, for the Groupe d'Etude et de Traitment du Carcinome Hepatocellulaire. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. J Hepatol 1999;31:133-141.
    • (1999) J Hepatol , vol.31 , pp. 133-141
    • Chevret, S.1    Trinchet, J.C.2    Mathieu, D.3    Rached, A.A.4    Beaugrand, M.5    Chastang, C.6
  • 12
    • 0032879468 scopus 로고    scopus 로고
    • Prognosis of hepatocellular carcinoma: The BCLC staging classification
    • Llovet JM, Brù C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329-337.
    • (1999) Semin Liver Dis , vol.19 , pp. 329-337
    • Llovet, J.M.1    Brù, C.2    Bruix, J.3
  • 13
    • 7344258851 scopus 로고    scopus 로고
    • Prognostic significance of pathological and biological factors in hepatocellular carcinoma
    • Ng IO. Prognostic significance of pathological and biological factors in hepatocellular carcinoma. J Gastroenterol Hepatol 1998;13:666-670.
    • (1998) J Gastroenterol Hepatol , vol.13 , pp. 666-670
    • Ng, I.O.1
  • 14
    • 0029160089 scopus 로고
    • Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis
    • Shimizu Y, Minemura M, Tsukishiro T, Kashii Y, Miyamoto M, Nishimori H, Higuchi K, et al. Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis. HEPATOLOGY 1995;22:525-531.
    • (1995) Hepatology , vol.22 , pp. 525-531
    • Shimizu, Y.1    Minemura, M.2    Tsukishiro, T.3    Kashii, Y.4    Miyamoto, M.5    Nishimori, H.6    Higuchi, K.7
  • 15
    • 0032958169 scopus 로고    scopus 로고
    • Soluble interleukin-2 receptor levels in hepatocellular cancer: A more sensitive marker than alfa fetoprotein
    • Izzo F, Cremona F, Delrio P, Leonardi E, Castello G, Pignata S, Daniele B, et al. Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein. Ann Surg Oncol 1999;6:178-185.
    • (1999) Ann Surg Oncol , vol.6 , pp. 178-185
    • Izzo, F.1    Cremona, F.2    Delrio, P.3    Leonardi, E.4    Castello, G.5    Pignata, S.6    Daniele, B.7
  • 17
    • 0030846249 scopus 로고    scopus 로고
    • Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma
    • Shiota G, Kishimoto Y, Suyama A, Okubo M, Katayama S, Harada K, Ishida M, et al. Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma. J Hepatol 1997;27:661-668.
    • (1997) J Hepatol , vol.27 , pp. 661-668
    • Shiota, G.1    Kishimoto, Y.2    Suyama, A.3    Okubo, M.4    Katayama, S.5    Harada, K.6    Ishida, M.7
  • 18
    • 0010460074 scopus 로고    scopus 로고
    • Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma
    • Saffroy R, Lelong JC, Azoulay D, Salvucci M, Reynes M, Bismuth H, Debuire B, et al. Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma. Br J Cancer 1999:79:604-610.
    • (1999) Br J Cancer , vol.79 , pp. 604-610
    • Saffroy, R.1    Lelong, J.C.2    Azoulay, D.3    Salvucci, M.4    Reynes, M.5    Bismuth, H.6    Debuire, B.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.